In June 2010, the Ugandan Ministry of Health (MOH) with support from the United States Agency for International Development (USAID)-funded Securing Ugandans�� Right to Essential Medicines (SURE) Program, collected data for the 2010 Pharmaceutical Sector Report. This report presents the findings of t...
The WHO Expert Committee on Specifications for Pharmaceutical Preparations met in Geneva from 14 to 18 October 2013. Dr M.-P. Kieny, Assistant Director-General of Health Systems and Innovation at the World Health Organization (WHO), welcomed participants on behalf of the Director-General. Dr Kieny t...
Problems related to the safety and quality of drugs exist in many places around the world today, in developing and developed countries alike. Some incidents have ended in tragedy, often with children as the victims. They are caused by the use of drugs containing toxic substances or impurities, drugs...
In 1985 WHO convened a conference in Nairobi on the rational use of drugs, since that time efforts have been increased to improve drug uses practices.An essential tool for such work is an objective measure of drug use in health facilities.
The recently unveiled African Union’s Bio-manufacturing Workforce Development Workshop Report 2023 and the United Nations Economic Development in Africa Report 2023 spotlight the critical role of a skilled and adaptable workforce. Additionally, the commitment of BRICS member states, Africa CDC, and...
The thirty-seventh meeting of the WHO Expert Committee on Drug Dependence (ECDD) took place in Geneva, Switzerland from 16 to 20 November 2015. Mr Cornelis de Joncheere, Director, WHO Department of Essential Medicines and Health Products (EMP), opened the meeting. He welcomed all participants on beh...
A standard operating procedure (SOP) is a set of systematic instructions compiled by an organization to help workers carry out complex routine operations. SOPs aim to achieve efficiency, quality output and uniformity of performance, while reducing miscommunication and failure to comply with regulati...
The WHO Expert Committee on Specifications for Pharmaceutical Preparations met in Geneva from 14 to 18 October 2013. Dr M.-P. Kieny, Assistant Director- General of Health Systems and Innovation at the World Health Organization (WHO), welcomed participants on behalf of the Director-General. Dr Kieny...
The World Health Organization (WHO), the United Nations Children��s Fund (UNICEF) and many other organizations are involved in the procurement of pharmaceutical products. In particular, the supply of pharmaceutical products used in the treatment of human immunodeficiency virus/acquired immunodeficie...
The Ministry of Health (MOH), through the Department of Pharmaceuticals and Natural Medicines (DPNM), executed the national integrated quantification for all Essential Medicines and Health Supplies (EMHS) for the financial year 2024/25.�As a result, the total commodity need for routine service deliv...
The Fifty-third meeting of the World Health Organization (WHO) Expert Committee on Specifications for Pharmaceutical Preparations (ECSPP) took place in Geneva, Switzerland, from 22 to 26 October 2018. Participants of the meeting were welcomed by Dr Mariângela Simão, Assistant Director-General, Acces...
The thirty-eighth meeting of the World Health Organization (WHO) Expert Committee on Drug Dependence (ECDD) took place in Geneva, Switzerland from 14 to 18 November 2016. Dr Suzanne Hill, Director, WHO Department of Essential Medicines and Health Products (EMP), opened the meeting. She welcomed all...
This manual was developed by the Pharmacy Division, Ministry of Health, in collaboration with the Securing Ugandans�� Right to Essential Medicines (SURE) Program with assistance from health workers representing all levels of care. The purpose of this manual is to provide health workers with a refere...
This manual represents the revised and updated edition of the Essential Medicines and Health Supplies�(EMHS) Management Manual, following its initial publication in 2012. The Department of�Pharmaceuticals and Natural Medicines (DPNM) of the Ministry of Health, in collaboration with�development partn...
The Ministry of Health (MoH) Department of Pharmaceuticals and Natural Medicines (DPNM) coordinated the first integrated quantification process for Essential Medicines and Health Supplies (EMHS) for the public and PNFP sector for Financial Years 2023/24 - 2025/26.�Quantification is a core component...
National quantification of EMHLS is an annual exercise conducted by NMS under the direct supervision of MoH, and the exercise is intended to provide all public sector players/stakeholder in the health sector with feedback about facility needs in accordance with the NMS Act Cap 207 that states in par...
The third National Pharmaceutical Sector Strategic Plan 2015/16-2019/20 (NPSSP III) has been developed to support the implementation of the National Medicines Policy (NMP) 2015. The NPSSP III was developed through wide consultations with diverse stakeholders including representatives from the privat...
The NMS Act Cap 207 states that the corporation shall advise the Ministry of Health, Ministry of Finance, Planning and Economic Development, Ministry of Local Government and National Drug Authority on essential issues relating to the state of the Corporation and its future development as well as to...
This report provides feedback on the FY2017/18 national quantification, an annual exercise conducted by NMS together with MoH and all government Health Facilities (HFs) and aimed to inform accurate planning for the supply of EMHLS in the public sector.
The World Health Organization (WHO) Expert Committee on Specifications for Pharmaceutical Preparations (ECSPP) met in Geneva from 16 to 20 October 2017.Dr Suzanne R. Hill, acting Assistant Director of the Health Systems and Innovation Cluster and Director of the Department of Essential Medicines and...
